Dr. Matthew Parsons Joins Network Immunology's Scientific Advisory Board

Released

Network Immunology, a preclinical stage biotech company focused on novel treatments to prevent and treat automimmune conditions and cancer, adds expert immunologists in the field of immune network science to its team. Dr. Sybille Muller and Dr. Heinz Kohler, who discovered and rearched NetVac™ molecule, have been appointed to the Board of Directors and Scientific Advisory Board, respectively.

Corporate Updates

Captcha Image